Growth impairment is common among JIA patients, ranging from retarded growth to local acceleration of growth in the body part affected, associated with increased production of pro-inflammatory cytokines (interleukin-1β-IL-1β, tumor necrosis factor-α-TNF-α, and interleukin-6-IL-6) [16]. This evidence concerns the gene IL6 and juvenile idiopathic arthritis.